SageMedic Corp.

We are so thrilled to share the impressive results of the European Multicenter study on Balloon Transarterial Chemoembolization (B-TACE). The nearly 60% complete response rate is a significant improvement over previously reported 22% of standard TACE, and it looks like this approach has the potential to more than double long-term survival rates. Looking ahead, the next step is to combine this selective balloon approach with the most promising treatment agents, which can now be identified through our SAGE Oncotest. This advancement brings renewed hope to many cancer patients. A huge thank you to all the researchers involved in this important work, and congratulations on these outstanding results! Together, we are making strides in the fight against cancer. 🌟 #CancerResearch #Innovation #Oncology #SageMedic

Don't miss our interview with Sanjay Juneja, M.D. We're covering several important topics: 1. How to catch cancer much earlier to "live long and prosper!" 2. Why current diagnostics, including genomic testing, fall short of finding the best therapy for you. 3. How the SAGE Oncotest can help you to receive the most effective treatment. https://lnkd.in/g9AAuH8v

Exciting News: SAGE will be presenting its progress and investment opportunity at the MedInvest Biotech & AI Conference on Wed, June 11th, 2024, in San Francisco. The event will primarily focus on medical devices and equipment, high-tech imaging, diagnostics, AI, data analytics, patient monitoring, and telemedicine. It will feature two days of company presentations and keynote talks and streamed to a remote audience primarily composed of investors outside of California. One-on-one meetings will take place both in-person and virtually. The focus on cutting-edge medical technologies includes medical devices, diagnostics, robotic tools, wearables, implantables, data analytics, digital health/telemedicine, AI/Big Data, clinical trials, patient monitoring, and consumer healthcare, among others. Speakers will include: Dr. Nigam Shah (Chief Data Scientist, Stanford Healthcare), Tamir Meiri (Director of Venture Investing, J&J Innovation), Paul LaViolette (Former COO and President of Boston Scientific, Managing Partner and COO, SV Health Investors), Lizzie Lee (McKesson Ventures), and many others. https://lnkd.in/dusxNE3 To register: https://lnkd.in/dFjJy4j

Are you attending the American Association of Cancer Research (AACR) Annual Meeting this weekend in San Diego? If yes, stop by our booth and win an Apple Watch or a pair of Bose QuietComfort Earbuds!

Check out this amazing podcast by Dr. Archelle Georgiou called: The Twists, Turns & Complexities of Cancer Treatment. This breast cancer patient journey illustrates the key points of self-advocacy, if you want to participate in your treatment decisions to get your best possible outcome you deserve! It's your life, advocate for yourself! https://lnkd.in/gZnJVNfE